Literature DB >> 16041200

Hypertension and cognitive functioning among the elderly: an overview.

Ofra Anson1, Esther Paran.   

Abstract

This paper reviews the longitudinal studies in which the association between hypertension and cognitive functioning has been explored. The findings of these studies are far from being consistent: positive, adverse, or no relationships between cognitive performance and blood pressure have been reported. In some studies, cognitive functioning was related only to systolic blood pressure, whereas in others, it was related to diastolic blood pressure alone. Most probably, the inconsistency is due to the variability in research design, the measures employed, and data management. Some of the main methodological issues are the wide range in the age of the subjects and the variability in hypertension at baseline. Length of exposure to hypertension was rarely considered, and the search for the possible effects of the different antihypertensive treatments on cognitive ability is in its infancy. Many studies seek to identify cognitively impaired elderly and do not distinguish between the different types of dementia or the different cognitive domains. Thus, the possibility that hypertension affects specific cognitive functions has not been explored. The use of subdivisions of blood pressure values may have obscured nonlinear relationship. Nevertheless, the pattern that emerges is that midlife hypertension enhances cognitive impairment later in life, but at old age, mild hypertension may increase cognitive performance. Directions for future research to further elucidate the complex relationship between age, blood pressure, and cognition are discussed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16041200     DOI: 10.1097/01.mjt.00001= 09849.55405.48

Source DB:  PubMed          Journal:  Am J Ther        ISSN: 1075-2765            Impact factor:   2.688


  7 in total

1.  Association between white matter microstructure, executive functions, and processing speed in older adults: the impact of vascular health.

Authors:  Heidi I L Jacobs; Elizabeth C Leritz; Victoria J Williams; Martin P J Van Boxtel; Wim van der Elst; Jelle Jolles; Frans R J Verhey; Regina E McGlinchey; William P Milberg; David H Salat
Journal:  Hum Brain Mapp       Date:  2011-09-23       Impact factor: 5.038

2.  Hypertension is associated with cognitive decline in elderly people at high risk for dementia.

Authors:  Michael Wysocki; Xiaodong Luo; James Schmeidler; Karen Dahlman; Gerson T Lesser; Hillel Grossman; Vahram Haroutunian; Michal Schnaider Beeri
Journal:  Am J Geriatr Psychiatry       Date:  2012-02       Impact factor: 4.105

3.  Sex and Age Differences in the Association of Blood Pressure and Hypertension with Cognitive Function in the Elderly: The Rancho Bernardo Study.

Authors:  D Kritz-Silverstein; G A Laughlin; L K McEvoy; E Barrett-Connor
Journal:  J Prev Alzheimers Dis       Date:  2017

4.  Less Alzheimer disease neuropathology in medicated hypertensive than nonhypertensive persons.

Authors:  L B Hoffman; J Schmeidler; G T Lesser; M S Beeri; D P Purohit; H T Grossman; V Haroutunian
Journal:  Neurology       Date:  2009-02-18       Impact factor: 9.910

5.  The dynamics of blood pressure and cognitive functioning: results from 6-year follow-up of an elderly cohort.

Authors:  Ester Paran; Ofra Anson
Journal:  J Clin Hypertens (Greenwich)       Date:  2011-08-24       Impact factor: 3.738

6.  Program of rehabilitative exercise and education to avert vascular events after non-disabling stroke or transient ischemic attack (PREVENT Trial): a multi-centred, randomised controlled trial.

Authors:  Marilyn MacKay-Lyons; Gordon Gubitz; Nicholas Giacomantonio; Howard Wightman; David Marsters; Kara Thompson; Chris Blanchard; Gail Eskes; Marianne Thornton
Journal:  BMC Neurol       Date:  2010-12-08       Impact factor: 2.474

7.  Brain Oscillations Elicited by the Cold Pressor Test: A Putative Index of Untreated Essential Hypertension.

Authors:  Christos Papageorgiou; Efstathios Manios; Eleftheria Tsaltas; Eleni Koroboki; Maria Alevizaki; Elias Angelopoulos; Meletios-Athanasios Dimopoulos; Charalabos Papageorgiou; Nikolaos Zakopoulos
Journal:  Int J Hypertens       Date:  2017-05-09       Impact factor: 2.420

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.